Inspire Medical sees Q4 revenue $239.5M-$239.7M, consensus $232.9M

Activated 72 new centers in the U.S. in the fourth quarter of 2024, bringing the total to 1,435 U.S. medical centers implanting Inspire therapy. Created 12 new sales territories in the U.S. in the fourth quarter of 2024, bringing the total to 335 U.S. sales territories Initiated the soft launch of the Inspire V neurostimulator with over 40 implants completed in Singapore and the U.S. Implemented a new organizational structure intended to drive continued growth.